In Focus, November 2008
News in focus, November 2008
Please click on any of the headlines below to see the full story.
The SERPING1 gene code influences the likelihood of developing age-related macular degeneration (AMD), according to study results published online ahead of print by The Lancet.
The discovery of factors affecting retinal angiogenesis have implications for the treatment of vascularization disorders, according to results of a study published in the October issue of Nature Medicine.
Bevacizumab (Avastin) may have an application as an adjunct to antifibrosis therapy, according to study results published in the October/November issue of the Journal of Glaucoma.
Competition winners.
For up-to-date news and announcements, please check the
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
